If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Scientists at Rutgers Health have made a groundbreaking discovery that could transform how asthma is diagnosed and monitored.

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

[39,40,41,42,43,44,45] Significant differences in health beliefs, experiences, and behaviors were observed between COPD patients with high medication adherence and suboptimal adherence. The ...

About Fexlamose Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve lung function, lessen symptoms and improve quality of life.

Chronic Obstructive Pulmonary Disease (COPD) and asthma are two prevalent respiratory diseases that significantly affect patients’ respiratory function and quality of life. Inhaled medications include ...

As the prevalence of COPD rises with age ... DPI device availability is limited to "controller" medications, while pMDI devices and nebulizers provide complete symptomatic coverage.